| Pharmaceutical active ingredients: |
| Daclizumab |
| Available forms, composition and doses of Zenapax: |
| Injectable; Injection; Daclizumab 5 mg / ml |
| Zenapax medical category: |
| Human:Immunosuppressants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L04AA08 - Daclizumab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheZuellig Pharma |
| Related documents and information about Zenapax: |
| Zenapax prescribing information (PDF) |